medigraphic.com
Instituto Nacional de Salud Pública

2019, Número 4

<< Anterior Siguiente >>

salud publica mex 2019; 61 (4)


Barreras e intervenciones innovadoras para la detección temprana del cáncer cervicouterino

Baezconde-Garbanati L, Agurto I, Gravitt PE, Luciani S, Murphy S, Ochoa C, Gallegos K, Barahona R, Rodríguez Y

Idioma: Ingles.
Referencias bibliográficas: 19
Paginas: 456-460
Archivo PDF: 271.57 Kb.


RESUMEN

El cáncer cervicouterino ha disminuido significativamente en los últimos 30 años, pero sigue siendo una de las principales causas de muerte entre mujeres de bajos recursos y minorías raciales/étnicas. Las tecnologías preventivas del cáncer cervicouterino no están siempre disponibles y los laboratorios no están siempre bien equipados para utilizarlas. La información sobre el VPH no ha sido difundida ampliamente. La OMS y datos de EEUU y Latinoamérica ofrecen estrategias para reducir el cáncer cervicouterino. El entendimiento de las barreras sistémicas, personales y culturales, dentro de un marco de toma de decisiones, y mensajes innovadores puede reducir las barreras asociadas con el cáncer cervicouterino en las Américas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Alfaro KM, Gage JC, Rosenbaum AJ, Ditzian LR, Maza M, Scarinci IC, et al. Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program. BMC Public Health. 2015;15:1058. https:// doi.org/10.1186/s12889-015-2360-7

  2. Petrocy A, Katz ML. Cervical cancer and HPV: Knowledge, attitudes, beliefs, and behaviors among women living in Guatemala. J Health Care Poor Underserved. 2014;25(2):624-36. https://doi.org/10.1353/hpu.2014.0084

  3. Gravitt P. Research on human papillomavirus and global cancer prevention: Translation of technological advances in cervical cancer prevention in high disease burden countries. Promoting Health Equity and Transnational Partnerships in Cancer Prevention and Control in the Americas Strategic Planning Summit; 2016 Oct 7; Panama City, Panama. https://healthequityamericas. usc.edu/summit/health-equity-research-summit/

  4. Baezconde-Garbanati L, Murphy ST, Moran MB, Cortessis VK. Reducing the excess burden of cervical cancer among Latinas: Translating science into health promotion initiatives. Calif J Health Promot. 2013;11(1):45-57.

  5. Bradley J, Coffey P, Arrossi S, Agurto I, Bingham A, Dzuba I, et al. Women’s perspectives on cervical screening and treatment in developing countries: Experiences with new technologies and service delivery strategies. Women Health. 2006;43(3):103-21. https://doi.org/10.1300/ J013v43n03_06

  6. Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, et al. Secondary prevention of cervical cancer: ASCO resource-stratified clinical practice guideline. J Glob Oncol. 2017;3(5): 635-57. https://doi.org/10.1200/ JGO.2016.006577 Cuzick J, Bergeron C, Doeberitz MVK, Gravitt P, Jeronimo J, Meijer JLM, et al. New technologies and procedures for cervical cancer screening. Vaccine. 2012; 30:F107-16. https://doi.org/10.1016/j.vaccine.2012.05.088

  7. World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: WHO, 2013 [cited 2013 Oct 2]. Available from: https://www.who.int/reproductivehealth/ publications/cancers/screening_and_treatment_of_precancerous_ lesions/en/

  8. Agurto I. Resultados de Focus Groups: comprensión de mensajes sobre VPH y cáncer cervicouterino. Promoting Health Equity and Transnational Partnerships in Cancer Prevention and Control in the Americas Strategic Planning Summit; 2016 Oct 7; Panama City. https://healthequityamericas. usc.edu/summit/health-equity-research-summit/

  9. Leyva M. Attitudes towards cervical cancer screening: A study of beliefs among women in Mexico. Calif J Health Promot. 2006;4(2):12-24. http:// citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.531.8604&rep=rep1 &type=pdf

  10. Vamos CA, Calvo AE, Daley EM, Giuliano AR, Lopez-Castillo H. Knowledge, behavioral, and sociocultural factors related to human papillomavirus infection and cervical cancer screening among inner-city women in Panama. J Community Health. 2015;40(6):1047-56. https://doi. org/10.1007/s10900-015-0030-4

  11. American Cancer Society. Cancer facts and figures for Hispanic/Latinos 2015-2017. Atlanta: American Cancer Society, 2015. [cited 2013 Oct 2] Available from: https://www.cancer.org/content/dam/cancer-org/research/ cancer-facts-and-statistics/cancer-facts-and-figures-for-hispanics-and-latinos/ cancer-facts-and-figures-for-hispanics-and-latinos-2015-2017.pdf

  12. Murphy S, Frank L, Chatterjee JS, Moran MB, Zhao N, Baezconde-Garbanati L. Comparing the relative efficacy of narrative versus non-narrative health messages in reducing health disparities using a randomized trial. Am J Public Health. 2015;105(10):2117-23. https://doi.org/10.2105/ AJPH.2014.302332

  13. Baezconde-Garbanati L, Chatterjee J, Frank L, Murphy S, Moran M, Werth L, et al. Tamale Lesson: A case study of a cancer narrative health communication intervention. J Commun Healthc. 2014;7(2):82-92. https:// doi.org/10.1179/1753807614Y.0000000055

  14. Paolino M, Arrossi S. Women’s knowledge about cervical cancer, Pap smear and human papillomavirus and its relation to screening in Argentina. Women Health. 2011;51(1):72-87. https://doi.org/10.1080/03630242.201 0.542547

  15. Soneji S, Fukui N. Socioeconomic determinants of cervical cancer screening in Latin America. Rev Panam Salud Publica. 2013;33(3):174-82. https://doi.org/10.1590/S1020-49892013000300003

  16. Bingham A, Bishop A, Coffey P, Winkler J, Bradley J, Dzuba I, et al. Factors affecting utilization of cervical cancer prevention services in lowresource settings. Salud Publica Mex. 2003;45(suppl 3):S408-16. https://doi. org/10.1590/S0036-36342003000900015

  17. Agurto I, Bishop A, Sánchez G, Betancourt Z, Robles S. Perceived barriers and benefits to cervical cancer screening in Latin America. Prev Med. 2004;39(1):91-8. https://doi.org/10.1016/j.ypmed.2004.03.040

  18. Baezconde-Garbanati L, Murphy S. Intervenciones innovadoras: Tamale Lesson and Es Tiempo. Promoting health equity and transnational partnerships in cancer prevention and control in the Americas Strategic Planning Summit; 2016 Oct 7; Panama City.

  19. Univeristy of Southern California. The Tamale Lesson: Narrative Education on Cervical Cancer [video]. California: USC, 2015 [cited 2013 Oct 2]. Available from: https://www.youtube.com/watch?v=Lyhv9KmLro




2020     |     www.medigraphic.com